262 related articles for article (PubMed ID: 36656570)
1. Desmopressin as a hemostatic and blood sparing agent in bleeding disorders.
Mohinani A; Patel S; Tan V; Kartika T; Olson S; DeLoughery TG; Shatzel J
Eur J Haematol; 2023 May; 110(5):470-479. PubMed ID: 36656570
[TBL] [Abstract][Full Text] [Related]
2. Desmopressin (DDAVP) for treatment of disorders of hemostasis.
Mannucci PM
Prog Hemost Thromb; 1986; 8():19-45. PubMed ID: 3104987
[TBL] [Abstract][Full Text] [Related]
3. The use of desmopressin as a hemostatic agent: a concise review.
Franchini M
Am J Hematol; 2007 Aug; 82(8):731-5. PubMed ID: 17492648
[TBL] [Abstract][Full Text] [Related]
4. Desmopressin: a nontransfusional treatment of hemophilia and von Willebrand disease.
Mannucci PM; Cattaneo M
Haemostasis; 1992; 22(5):276-80. PubMed ID: 1478539
[TBL] [Abstract][Full Text] [Related]
5. Nasal spray desmopressin (DDAVP) for mild hemophilia A and von Willebrand disease.
Rose EH; Aledort LM
Ann Intern Med; 1991 Apr; 114(7):563-8. PubMed ID: 1900403
[TBL] [Abstract][Full Text] [Related]
6. Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type I.
Lethagen S; Harris AS; Nilsson IM
Blut; 1990 Mar; 60(3):187-91. PubMed ID: 2107887
[TBL] [Abstract][Full Text] [Related]
7. How I treat patients with von Willebrand disease.
Mannucci PM
Blood; 2001 Apr; 97(7):1915-9. PubMed ID: 11264151
[TBL] [Abstract][Full Text] [Related]
8. Desmopressin: an historical introduction.
Mannucci PM
Haemophilia; 2008 Jan; 14 Suppl 1():1-4. PubMed ID: 18173688
[TBL] [Abstract][Full Text] [Related]
9. Factor VIII and von Willebrand factor changes after desmopressin and during pregnancy in type 2M von Willebrand disease Vicenza: a prospective study comparing patients with single (R1205H) and double (R1205H-M740I) defect.
Castaman G; Federici AB; Bernardi M; Moroni B; Bertoncello K; Rodeghiero F
J Thromb Haemost; 2006 Feb; 4(2):357-60. PubMed ID: 16420565
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of parenteral formulations of desmopressin in the treatment of bleeding disorders: A systematic review.
Sreeraman S; McKinlay S; Li A; Crowther M; Motalo O
Thromb Res; 2022 May; 213():16-26. PubMed ID: 35278886
[TBL] [Abstract][Full Text] [Related]
11. Review of clinical experience of desmopressin in patients with congenital and acquired bleeding disorders.
Cattaneo M
Eur J Anaesthesiol Suppl; 1997 Mar; 14():10-4; discussion 14-8. PubMed ID: 9088829
[TBL] [Abstract][Full Text] [Related]
12. Treatment of von Willebrand disease.
Rodeghiero F; Castaman G
Semin Hematol; 2005 Jan; 42(1):29-35. PubMed ID: 15662613
[TBL] [Abstract][Full Text] [Related]
13. Acquired von Willebrand disease--hemostatic management of major orthopedic surgery with high-dose immunoglobulin, desmopressin, and continuous factor concentrate infusion.
Frank RD; Kunz D; Wirtz DC
Am J Hematol; 2002 May; 70(1):64-71. PubMed ID: 11994985
[TBL] [Abstract][Full Text] [Related]
14. A trial of desmopressin (1-desamino-8-D-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery.
Hackmann T; Gascoyne RD; Naiman SC; Growe GH; Burchill LD; Jamieson WR; Sheps SB; Schechter MT; Townsend GE
N Engl J Med; 1989 Nov; 321(21):1437-43. PubMed ID: 2682243
[TBL] [Abstract][Full Text] [Related]
15. Desmopressin (DDAVP) and hemostasis.
Lethagen S
Ann Hematol; 1994 Oct; 69(4):173-80. PubMed ID: 7948303
[TBL] [Abstract][Full Text] [Related]
16. Vasopressin analogues. Their role in disorders of hemostasis.
Mannuccio PM; Altieri D; Faioni E
Ann N Y Acad Sci; 1987; 509():71-81. PubMed ID: 3122621
[TBL] [Abstract][Full Text] [Related]
17. Desmopressin (DDAVP) in the management of patients with congenital bleeding disorders.
Leissinger C; Carcao M; Gill JC; Journeycake J; Singleton T; Valentino L
Haemophilia; 2014 Mar; 20(2):158-67. PubMed ID: 23937614
[TBL] [Abstract][Full Text] [Related]
18. von Willebrand factor and factor VIII levels after desmopressin are associated with bleeding phenotype in type 1 VWD.
Atiq F; Schütte LM; Looijen AEM; Boender J; Cnossen MH; Eikenboom J; de Maat MPM; Kruip MJHA; Leebeek FWG
Blood Adv; 2019 Dec; 3(24):4147-4154. PubMed ID: 31834934
[TBL] [Abstract][Full Text] [Related]
19. Treatment of von Willebrand disease.
Mannucci PM
Haemophilia; 1998 Jul; 4(4):661-4. PubMed ID: 9873811
[TBL] [Abstract][Full Text] [Related]
20. Desmopressin-related myocardial infarction in a patient with Wegener's granulomatosis: a case report and review of the literature.
Pape E; Béné J; Buchdahl AL; Gautier S; Hatron PY; Lambert M
J Mal Vasc; 2013 Feb; 38(1):43-6. PubMed ID: 23265678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
